Post-extubation dysphagia (PED) recently became a growing concern as a major risk factor for extubation failure and significant contributor to poor patient outcomes with prevalence rates ranging from 12% to 69%, being highest in neurological patients (93%). Pharyngeal electrical stimulation (PES) has been shown to improve airway safety and swallowing function tracheostomized stroke patients, thereby enhancing decannulation in this patient cohort. In the present study the investigators evaluate whether PES is safe, feasible and effective in orotracheal intubated stroke patients at high risk of extubation failure.
Endotracheal intubation and mechanical ventilation are common procedures for critically ill stroke patients. Although necessary and life-saving, timely extubation after ventilator weaning is desirable, because patients with delayed extubation experience higher pneumonia rate, increased need for tracheostomy, longer length of stay on the intensive care unit and higher mortality. On the other hand, extubation failure (EF) and subsequent need for emergent re-intubation is associated with similar sequelae. Post-extubation dysphagia (PED) became a growing concern as a major risk factor for EF and significant contributor to poor patient outcomes with prevalence rates ranging from 12% to 69%, being highest in neurological patients (93%). Damage to the central swallowing network itself is the primary cause of PED in cerebrovascular disease, which constitutes the leading diagnosis on neuro-ICUs. Further mechanisms include pharyngolaryngeal lesions caused by the tube, critical illness neuropathy and myopathy leading to muscle weakness and dyscoordination of breathing and swallowing, and an impaired sensation due to sedation, mucosal damage, or the underlying critical illness itself. As a consequence reintubation rates in neurological collectives are as high as 20 to 40%. Pharyngeal electrical stimulation (PES) has been shown to improve airway safety and swallowing function tracheostomized stroke patients, thereby enhancing decannulation in this patient cohort. In the present study the investigators evaluate whether PES is safe, feasible and effective in orotracheal intubated stroke patients at high risk of extubation failure.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
PES will be delivered by a commercial device (Phagenyx, Phagenesis Ltd, Manchester, UK), which comprises a nasogastric feeding catheter that houses stimulation ring-electrodes and a computerised base station that delivers stimulation in the range 1-50 mA at 5 Hz.
University Hospital Münster, Deparment of Neurology
Münster, Germany
RECRUITINGSuccessful extubation
No re-intubation within 72 hours after extubation
Time frame: 72 hours after extubation
Pneumonia
Pneumonia post extubation until hospital discharge
Time frame: up to 14 days
Feeding status
Functional Oral Intake Scale
Time frame: up to 14 days
Swallowing function
Fiberoptic Endoscopic Dysphagia Severity Scale
Time frame: 0-24 hours after extubation
Swallowing function
Fiberoptic Endoscopic Dysphagia Severity Scale
Time frame: 72-120 hours after extubation
Swallowing function
Fiberoptic Endoscopic Dysphagia Severity Scale
Time frame: up to 14 days
Length of stay of the ICU/intermediate care
Length of stay in days
Time frame: up to 60 days
Length of stay in hospital
Length of stay in hospital in days
Time frame: up to 120 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.